PnuVax Inc has received a $29.4 million grant from the Bill & Melinda Gates Foundation to further develop and clinically evaluate its pneumococcal conjugate vaccine. Milestone payments will be received over the next three years as the vaccine progresses from process development through to biomanufacturing scale-up and proof-of-concept clinical trials,…
Source: RT
Read more: M Gates Foundation Grant to Fund Pneumococcal Vaccine